Schedule & Agenda
Registration, networking and coffee
Welcome, Uffe Mark Hansen, Chairman of the Board of Life Science Law DK, Head of Legal, Novartis Healthcare A/S
Eva Rytter Sunesen, Head of Trade and FDI, PhD, Copenhagen Economics
What does Brexit mean for Danish companies with interests in the UK?
Claus Andersen and Thomas Bjørn, partners, Royds Withy King (post in English)
Laura Collister, Brexit Lead, Bio Industry Association (BIA)
What does Brexit mean for the interests of Danish companies in Denmark?
Dr. Sven J.R. Bostyn, Lic.Jur., LLM, PhD, Associate Professor of Biomedical Innovation Law at CeBIL, and Professor, Jur.Dr. Timo Minssen, LL.Lic., LL.M., M.I.C.L., Director at CeBIL, University of Copenhagen
Mikkel Møller Rasmussen, Chief Consultant, Pharmaceutical Industry (LIF)
Rounding off and Networking